Suppr超能文献

用胰高血糖素或甘露庚酮糖处理大鼠可增加肝脏线粒体3-羟基-3-甲基戊二酰辅酶A合酶的活性,并降低琥珀酰辅酶A的含量。

Treatment of rats with glucagon or mannoheptulose increases mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase activity and decreases succinyl-CoA content in liver.

作者信息

Quant P A, Tubbs P K, Brand M D

机构信息

Department of Biochemistry, University of Cambridge, U.K.

出版信息

Biochem J. 1989 Aug 15;262(1):159-64. doi: 10.1042/bj2620159.

Abstract
  1. The activity of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (EC 4.1.3.5) in extracts of rapidly frozen rat livers was doubled in animals treated in various ways to increase ketogenic flux. 2. Some 90% of the activity measured was mitochondrial, and changes in mitochondrial activity dominated changes in total enzyme activity. 3. The elevated HMG-CoA synthase activities persisted throughout the isolation of liver mitochondria. 4. Intramitochondrial succinyl-CoA content was lower in whole liver homogenates and in mitochondria isolated from animals treated with glucagon or mannoheptulose. 5. HMG-CoA synthase activity in mitochondria from both ox and rat liver was negatively correlated with intramitochondrial succinyl-CoA levels when these were manipulated artificially. Under these conditions, the differences between mitochondria from control and hormone-treated rats were abolished. 6. These findings show that glucagon can decrease intramitochondrial succinyl-CoA concentration, and that this in turn can regulate mitochondrial HMG-CoA synthase. They support the hypothesis that the formation of ketone bodies from acetyl-CoA may be regulated by the extent of succinylation of mitochondrial HMG-CoA synthase.
摘要
  1. 在以各种方式处理以增加生酮通量的动物中,快速冷冻的大鼠肝脏提取物中3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)合酶(EC 4.1.3.5)的活性增加了一倍。2. 所测活性约90%存在于线粒体中,线粒体活性的变化主导了总酶活性的变化。3. 在整个肝脏线粒体分离过程中,HMG-CoA合酶活性持续升高。4. 在全肝匀浆以及从用胰高血糖素或甘露庚酮糖处理的动物分离得到的线粒体中,线粒体内琥珀酰辅酶A含量较低。5. 当人工调控时,牛和大鼠肝脏线粒体中的HMG-CoA合酶活性与线粒体内琥珀酰辅酶A水平呈负相关。在这些条件下,对照大鼠和激素处理大鼠的线粒体之间的差异消失。6. 这些发现表明,胰高血糖素可降低线粒体内琥珀酰辅酶A浓度,进而可调节线粒体HMG-CoA合酶。它们支持这样的假说,即由乙酰辅酶A生成酮体可能受线粒体HMG-CoA合酶琥珀酰化程度的调节。

相似文献

引用本文的文献

1
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.肝脏生酮作用在脂肪性肝病中的新作用
Front Physiol. 2022 Jul 4;13:946474. doi: 10.3389/fphys.2022.946474. eCollection 2022.
6
β-Hydroxybutyrate: A Signaling Metabolite.β-羟基丁酸:一种信号代谢物。
Annu Rev Nutr. 2017 Aug 21;37:51-76. doi: 10.1146/annurev-nutr-071816-064916.
8
β-hydroxybutyrate: much more than a metabolite.β-羟基丁酸:远不止是一种代谢产物。
Diabetes Res Clin Pract. 2014 Nov;106(2):173-81. doi: 10.1016/j.diabres.2014.08.009. Epub 2014 Aug 19.
10
Ketone bodies as signaling metabolites.酮体作为信号代谢物。
Trends Endocrinol Metab. 2014 Jan;25(1):42-52. doi: 10.1016/j.tem.2013.09.002. Epub 2013 Oct 18.

本文引用的文献

2
Decrease by glucagon in hepatic succinyl-CoA.肝脏琥珀酰辅酶A中胰高血糖素使其减少。
Biochem Biophys Res Commun. 1980 Jul 16;95(1):205-11. doi: 10.1016/0006-291x(80)90725-1.
9
Determination of sulfhydryl groups with 2,2'- or 4,4'-dithiodipyridine.用2,2'-或4,4'-二硫代二吡啶测定巯基
Arch Biochem Biophys. 1967 Mar;119(1):41-9. doi: 10.1016/0003-9861(67)90426-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验